LATAM BNP NT-proBNP Market Size & Outlook, 2026-2034


LATAM BNP NT-proBNP Market Insights

  • Reed Intelligence analysis indicates that the LATAM BNP NT-proBNP Market size, which was USD 147.29 Million in 2025, is projected to attain USD 279.16 Million by 2034.
  • The market is expected to register a CAGR of 7.36% over the period 2026–2034.
  • In 2025, BNP Assays emerged as the dominant Test Type based on market size.
  • BNP Assays is projected to register the fastest growth, positioning it as the most attractive Test Type segment over the forecast horizon.

Other Key Findings


  • LATAM held 5.01% share of the global BNP NT-proBNP Market size in 2025.
  • United States is expected to remain the largest contributor to the global market size by 2034.
  • By 2034, Colombia is anticipated to record the highest growth in LATAM, with the market size expected to reach USD 22.6 Million.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 147.29 Million
Market Size In 2034 USD 279.16 Million
Largest segment BNP Assays
Units Revenue in USD Million
CAGR 7.36% (2026-2034)
Segmnetation Covered
LATAM
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
Test Type
  1. BNP Assays
  2. NT-proBNP Assays
Technology
  1. Immunoassay Platforms
  2. Fluorescence Immunoassays
  3. Chemiluminescence Assays
  4. Point-of-Care Testing Systems
Application
  1. Heart Failure Diagnosis
  2. Cardiovascular Risk Assessment
  3. Acute Coronary Syndrome Management
  4. Chronic Disease Monitoring
End-Use
  1. Hospitals
  2. Diagnostic Laboratories
  3. Ambulatory Care Centers
  4. Home Healthcare Settings
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends